# GO_molecular_function_0060: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/GO_molecular_function_0060.txt)

**Task:** `GO_molecular_function`  
**Author key, unchanged:** **B** — ubiquitin-like protein transferase activity

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MISAPSPDHLLLEQDLATPEIRCGEIEERWRHIRTSWPHVFFAVSAPQRPNGPKEFGFRFEYTGYRQTPVTAQLWDLEADAPLPHAKWPTGTYVVPSVFRKDWQQGNCLYIPCDRISIQGHTAWLNDHPSRLWQPARGIICYLEQLYELFNQGDYTGLVSA

[Multiple Choices]
A. peptidyl-lysine 3-dioxygenase activity
B. ubiquitin-like protein transferase activity
C. potassium channel regulator activity
D. enzyme activator activity
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Molecular Function Prediction, which is to predict the fundamental activity of a protein at the molecular level, as defined by the Gene Ontology (GO) 'Molecular Function' branch. This describes the elemental tasks a protein performs, such as catalysis, transport, or binding to specific molecules. Based on the protein's amino acid sequence, you are to select the option that best describes its primary molecular function.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence exactly matches the UniProt record for BilB. That record describes BilB as an E2-like enzyme that transfers a ubiquitin-like moiety to target proteins, and annotates ubiquitin-like protein transferase activity with IDA evidence. This supports choice B for the supplied sequence.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [C7](#evidence-c7), [H3](#evidence-h3), [H5](#evidence-h5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The short sequence might permit family-level clues, but the input gives no organism, pathway, substrate, or functional context that establishes BilB's role in the Bil system. The particular transferase function is not meaningfully distinguished from the choices by a concrete argument available from the supplied input alone.


**Missing item-specific fact**

> That this particular protein is BilB, an E2-like component of a bacterial ubiquitin-like protein conjugation system, and transfers the ubiquitin-like moiety to target proteins.


**Reason**

> The key is supported by protein-specific annotation and experimental evidence, but those facts are absent from the evaluated input. Recognizing or retrieving the exact protein's identity and function would be lookup or memorization, not reasoning from the supplied sequence and choices.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied evidence supports B; no other listed choice is supported as a molecular function of this protein.


### Important caveats

- The UniProt record and GO annotation match the supplied sequence, but the exact source snapshot used by the author is unknown.
- The protein-specific functional evidence is reviewer-only and was not supplied to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The short sequence might permit family-level clues, but the input gives no organism, pathway, substrate, or functional context that establishes BilB's role in the Bil system. The particular transferase function is not meaningfully distinguished from the choices by a concrete argument available from the supplied input alone.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "That this particular protein is BilB, an E2-like component of a bacterial ubiquitin-like protein conjugation system, and transfers the ubiquitin-like moiety to target proteins.",
    "reason": "The key is supported by protein-specific annotation and experimental evidence, but those facts are absent from the evaluated input. Recognizing or retrieving the exact protein's identity and function would be lookup or memorization, not reasoning from the supplied sequence and choices."
  },
  "case_id": "GO_molecular_function_0060",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "C7",
      "H3",
      "H5"
    ],
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt record for BilB. That record describes BilB as an E2-like enzyme that transfers a ubiquitin-like moiety to target proteins, and annotates ubiquitin-like protein transferase activity with IDA evidence. This supports choice B for the supplied sequence."
  },
  "important_caveats": [
    "The UniProt record and GO annotation match the supplied sequence, but the exact source snapshot used by the author is unknown.",
    "The protein-specific functional evidence is reviewer-only and was not supplied to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence supports B; no other listed choice is supported as a molecular function of this protein."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_molecular_function_0060",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt record for BilB. That record describes BilB as an E2-like enzyme that transfers a ubiquitin-like moiety to target proteins, and annotates ubiquitin-like protein transferase activity with IDA evidence. This supports choice B for the supplied sequence.",
    "evidence_ids": ["C1", "C5", "C7", "H3", "H5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The short sequence might permit family-level clues, but the input gives no organism, pathway, substrate, or functional context that establishes BilB's role in the Bil system. The particular transferase function is not meaningfully distinguished from the choices by a concrete argument available from the supplied input alone.",
    "missing_item_specific_fact": "That this particular protein is BilB, an E2-like component of a bacterial ubiquitin-like protein conjugation system, and transfers the ubiquitin-like moiety to target proteins.",
    "reason": "The key is supported by protein-specific annotation and experimental evidence, but those facts are absent from the evaluated input. Recognizing or retrieving the exact protein's identity and function would be lookup or memorization, not reasoning from the supplied sequence and choices."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence supports B; no other listed choice is supported as a molecular function of this protein."
  },
  "important_caveats": [
    "The UniProt record and GO annotation match the supplied sequence, but the exact source snapshot used by the author is unknown.",
    "The protein-specific functional evidence is reviewer-only and was not supplied to the evaluated model."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A1I1NU27 (sequence SHA256 match confirmed) is annotated with GO:0019787 'ubiquitin-like protein transferase activity' with evidence code IDA:UniProtKB, supported by experimental data from Hoer et al. (Nature 2024, PMID:39020165). The protein is named 'Bacterial E2-like ubiquitin protein BilB' (EC 2.3.2.-) and functions as the E2 component of the Bil conjugation system, catalyzing covalent attachment of a ubiquitin-like moiety (BilA) to phage target proteins. The GO term matches option B exactly.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C7](#evidence-c7), [C8](#evidence-c8), [H3](#evidence-h3), [H5](#evidence-h5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> Partial elimination reasoning is possible: the sequence lacks 2-oxoglutarate-dependent dioxygenase motifs (rules out A), lacks transmembrane or ion-channel-binding features (rules out C), and the GO definition of enzyme activator activity (GO:0008047) explicitly excludes covalent modification, which is inconsistent with a transferase mechanism (weakly argues against D). However, positively identifying the protein as specifically a 'ubiquitin-like protein transferase' requires recognizing the UBC/E2 fold from a 161-residue bacterial sequence with a catalytic Cys-113, or knowing the Bil system (described only in 2024). The UBC fold is not trivially identifiable from primary sequence text without structural context or database comparison.


**Missing item-specific fact**

> The specific identity of this protein as BilB (E2 of the bacterial ISG15-like Bil antiviral system, described in Hoer et al. Nature 2024) and recognition of the E2/UBC catalytic fold from this particular bacterial sequence. Without prior knowledge of this novel 2024 system or the ability to computationally match the UBC fold, a model cannot positively assign 'ubiquitin-like protein transferase activity' over other small Cys-containing protein functions.


**Reason**

> While elimination of A and C is feasible through general motif knowledge, the positive identification of B requires either recognizing the exact sequence (lookup), knowing the 2024 Bil system publication, or identifying the UBC fold from primary sequence alone—which is a specialized structural biology skill not achievable from the text sequence without tools. The bacterial context further makes E2 identification non-obvious. The question effectively tests knowledge of a very recently characterized, protein-specific annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options represent mechanistically distinct GO terms: dioxygenase (A), transferase (B), channel regulator (C), and enzyme activator (D). The GO definitions are mutually exclusive in practice. Option D is explicitly excluded by the GO definition (no covalent modification allowed), and A/C lack any sequence support. No two options are simultaneously defensible.


### Important caveats

- The Bil system was described in a single 2024 Nature paper (Hoer et al.); this is an extremely novel annotation with limited literature.
- The GO annotation uses IDA (Inferred from Direct Assay) evidence, indicating experimental support, not purely computational inference.
- The protein is bacterial, making E2-like activity unusual and harder to predict from general biological priors that associate E2 enzymes primarily with eukaryotes.
- The reviewer-only evidence confirms sequence match and annotation but was absent from the evaluated model input; the model had only the raw sequence and four options.
- The catalytic Cys-113 (confirmed by mutagenesis in the reference) is present in the sequence, but recognizing it as an E2 catalytic residue without fold-level knowledge is very difficult.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Partial elimination reasoning is possible: the sequence lacks 2-oxoglutarate-dependent dioxygenase motifs (rules out A), lacks transmembrane or ion-channel-binding features (rules out C), and the GO definition of enzyme activator activity (GO:0008047) explicitly excludes covalent modification, which is inconsistent with a transferase mechanism (weakly argues against D). However, positively identifying the protein as specifically a 'ubiquitin-like protein transferase' requires recognizing the UBC/E2 fold from a 161-residue bacterial sequence with a catalytic Cys-113, or knowing the Bil system (described only in 2024). The UBC fold is not trivially identifiable from primary sequence text without structural context or database comparison.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific identity of this protein as BilB (E2 of the bacterial ISG15-like Bil antiviral system, described in Hoer et al. Nature 2024) and recognition of the E2/UBC catalytic fold from this particular bacterial sequence. Without prior knowledge of this novel 2024 system or the ability to computationally match the UBC fold, a model cannot positively assign 'ubiquitin-like protein transferase activity' over other small Cys-containing protein functions.",
    "reason": "While elimination of A and C is feasible through general motif knowledge, the positive identification of B requires either recognizing the exact sequence (lookup), knowing the 2024 Bil system publication, or identifying the UBC fold from primary sequence alone—which is a specialized structural biology skill not achievable from the text sequence without tools. The bacterial context further makes E2 identification non-obvious. The question effectively tests knowledge of a very recently characterized, protein-specific annotation."
  },
  "case_id": "GO_molecular_function_0060",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C7",
      "C8",
      "H3",
      "H5"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A1I1NU27 (sequence SHA256 match confirmed) is annotated with GO:0019787 'ubiquitin-like protein transferase activity' with evidence code IDA:UniProtKB, supported by experimental data from Hoer et al. (Nature 2024, PMID:39020165). The protein is named 'Bacterial E2-like ubiquitin protein BilB' (EC 2.3.2.-) and functions as the E2 component of the Bil conjugation system, catalyzing covalent attachment of a ubiquitin-like moiety (BilA) to phage target proteins. The GO term matches option B exactly."
  },
  "important_caveats": [
    "The Bil system was described in a single 2024 Nature paper (Hoer et al.); this is an extremely novel annotation with limited literature.",
    "The GO annotation uses IDA (Inferred from Direct Assay) evidence, indicating experimental support, not purely computational inference.",
    "The protein is bacterial, making E2-like activity unusual and harder to predict from general biological priors that associate E2 enzymes primarily with eukaryotes.",
    "The reviewer-only evidence confirms sequence match and annotation but was absent from the evaluated model input; the model had only the raw sequence and four options.",
    "The catalytic Cys-113 (confirmed by mutagenesis in the reference) is present in the sequence, but recognizing it as an E2 catalytic residue without fold-level knowledge is very difficult."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent mechanistically distinct GO terms: dioxygenase (A), transferase (B), channel regulator (C), and enzyme activator (D). The GO definitions are mutually exclusive in practice. Option D is explicitly excluded by the GO definition (no covalent modification allowed), and A/C lack any sequence support. No two options are simultaneously defensible."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_molecular_function_0060",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A1I1NU27 (sequence SHA256 match confirmed) is annotated with GO:0019787 'ubiquitin-like protein transferase activity' with evidence code IDA:UniProtKB, supported by experimental data from Hoer et al. (Nature 2024, PMID:39020165). The protein is named 'Bacterial E2-like ubiquitin protein BilB' (EC 2.3.2.-) and functions as the E2 component of the Bil conjugation system, catalyzing covalent attachment of a ubiquitin-like moiety (BilA) to phage target proteins. The GO term matches option B exactly.",
    "evidence_ids": ["C4", "C5", "C7", "C8", "H3", "H5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "Partial elimination reasoning is possible: the sequence lacks 2-oxoglutarate-dependent dioxygenase motifs (rules out A), lacks transmembrane or ion-channel-binding features (rules out C), and the GO definition of enzyme activator activity (GO:0008047) explicitly excludes covalent modification, which is inconsistent with a transferase mechanism (weakly argues against D). However, positively identifying the protein as specifically a 'ubiquitin-like protein transferase' requires recognizing the UBC/E2 fold from a 161-residue bacterial sequence with a catalytic Cys-113, or knowing the Bil system (described only in 2024). The UBC fold is not trivially identifiable from primary sequence text without structural context or database comparison.",
    "missing_item_specific_fact": "The specific identity of this protein as BilB (E2 of the bacterial ISG15-like Bil antiviral system, described in Hoer et al. Nature 2024) and recognition of the E2/UBC catalytic fold from this particular bacterial sequence. Without prior knowledge of this novel 2024 system or the ability to computationally match the UBC fold, a model cannot positively assign 'ubiquitin-like protein transferase activity' over other small Cys-containing protein functions.",
    "reason": "While elimination of A and C is feasible through general motif knowledge, the positive identification of B requires either recognizing the exact sequence (lookup), knowing the 2024 Bil system publication, or identifying the UBC fold from primary sequence alone—which is a specialized structural biology skill not achievable from the text sequence without tools. The bacterial context further makes E2 identification non-obvious. The question effectively tests knowledge of a very recently characterized, protein-specific annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent mechanistically distinct GO terms: dioxygenase (A), transferase (B), channel regulator (C), and enzyme activator (D). The GO definitions are mutually exclusive in practice. Option D is explicitly excluded by the GO definition (no covalent modification allowed), and A/C lack any sequence support. No two options are simultaneously defensible."
  },
  "important_caveats": [
    "The Bil system was described in a single 2024 Nature paper (Hoer et al.); this is an extremely novel annotation with limited literature.",
    "The GO annotation uses IDA (Inferred from Direct Assay) evidence, indicating experimental support, not purely computational inference.",
    "The protein is bacterial, making E2-like activity unusual and harder to predict from general biological priors that associate E2 enzymes primarily with eukaryotes.",
    "The reviewer-only evidence confirms sequence match and annotation but was absent from the evaluated model input; the model had only the raw sequence and four options.",
    "The catalytic Cys-113 (confirmed by mutagenesis in the reference) is present in the sequence, but recognizing it as an E2 catalytic residue without fold-level knowledge is very difficult."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record describes BilB as an E2-like ubiquitin protein and reports its role in transferring a ubiquitin-like moiety to phage proteins. The record also assigns the matching GO term, ubiquitin-like protein transferase activity. The catalytic step is described as probable, but the overall transferase assignment is supported.

Citations as saved: [C5](#evidence-c5), [C7](#evidence-c7).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

Empty string, as saved.


**Missing item-specific fact**

> That this particular sequence is BilB in the Bil antiviral system and participates in ubiquitin-like protein transfer; this exact functional context is absent from the input.


**Reason**

> The short, soluble sequence does not by itself provide a clear, diagnostic basis for choosing ubiquitin-like transferase activity over the broad enzyme-activator option. A family-level inference would help if the Bil/E2-like identity were established, but the original input supplies no context establishing that identity, and the sequence alone offers no clearly diagnostic feature here.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The source supports B for the specific protein; the other choices are not supported by the supplied sequence-specific evidence.


### Important caveats

- The source record matches the supplied sequence, but the author's exact source snapshot is unknown.
- The detailed BilB functional annotation includes a probable catalytic step; it is not a claim that every mechanistic detail is experimentally established.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "That this particular sequence is BilB in the Bil antiviral system and participates in ubiquitin-like protein transfer; this exact functional context is absent from the input.",
    "reason": "The short, soluble sequence does not by itself provide a clear, diagnostic basis for choosing ubiquitin-like transferase activity over the broad enzyme-activator option. A family-level inference would help if the Bil/E2-like identity were established, but the original input supplies no context establishing that identity, and the sequence alone offers no clearly diagnostic feature here."
  },
  "case_id": "GO_molecular_function_0060",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C7"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record describes BilB as an E2-like ubiquitin protein and reports its role in transferring a ubiquitin-like moiety to phage proteins. The record also assigns the matching GO term, ubiquitin-like protein transferase activity. The catalytic step is described as probable, but the overall transferase assignment is supported."
  },
  "important_caveats": [
    "The source record matches the supplied sequence, but the author's exact source snapshot is unknown.",
    "The detailed BilB functional annotation includes a probable catalytic step; it is not a claim that every mechanistic detail is experimentally established."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The source supports B for the specific protein; the other choices are not supported by the supplied sequence-specific evidence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_molecular_function_0060",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record describes BilB as an E2-like ubiquitin protein and reports its role in transferring a ubiquitin-like moiety to phage proteins. The record also assigns the matching GO term, ubiquitin-like protein transferase activity. The catalytic step is described as probable, but the overall transferase assignment is supported.",
    "evidence_ids": ["C5", "C7"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "",
    "missing_item_specific_fact": "That this particular sequence is BilB in the Bil antiviral system and participates in ubiquitin-like protein transfer; this exact functional context is absent from the input.",
    "reason": "The short, soluble sequence does not by itself provide a clear, diagnostic basis for choosing ubiquitin-like transferase activity over the broad enzyme-activator option. A family-level inference would help if the Bil/E2-like identity were established, but the original input supplies no context establishing that identity, and the sequence alone offers no clearly diagnostic feature here."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The source supports B for the specific protein; the other choices are not supported by the supplied sequence-specific evidence."
  },
  "important_caveats": [
    "The source record matches the supplied sequence, but the author's exact source snapshot is unknown.",
    "The detailed BilB functional annotation includes a probable catalytic step; it is not a claim that every mechanistic detail is experimentally established."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0A1I1NU27 explicitly annotates this protein with GO:0019787 (ubiquitin-like protein transferase activity) with evidence code IDA:UniProtKB, backed by experimental evidence from PubMed:39020165 (Hoer, Wolf, Sorek, Nature 2024). The protein is named 'Bacterial E2-like ubiquitin protein BilB' (EC 2.3.2.-) and functions as the E2 component of the Bil antiviral defense system, conjugating ubiquitin-like moieties to phage target proteins. The GO term definition (catalysis of transfer of a ubiquitin-like from one protein to another via covalent linkage) matches the described mechanism.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C7](#evidence-c7), [C8](#evidence-c8), [H3](#evidence-h3), [H5](#evidence-h5).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> A knowledgeable model can apply several transferable principles: (1) E2 ubiquitin-conjugating enzymes are characteristically small (~150-200 AA) with a catalytic cysteine; this protein is 161 AA with a probable catalytic Cys-113 in the context 'IPCDR', fitting the E2 size/catalytic-cysteine paradigm. (2) Option A (peptidyl-lysine 3-dioxygenase) requires 2-oxoglutarate-dependent dioxygenase motifs (Fe(II)-coordinating HxD/E...H triad, larger protein ~300+ AA); none are present. (3) Option C (potassium channel regulator) requires channel-binding domains and often transmembrane segments; the sequence lacks both. (4) Option D (enzyme activator, GO:0008047) is defined as increasing catalytic activity WITHOUT covalent modification; a catalytic cysteine in a small protein implies covalent transfer chemistry, which contradicts the activator definition and aligns with E2 transferase. The combination of small size + catalytic Cys + absence of dioxygenase/channel features + covalent-modification implication meaningfully favors B over the alternatives.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The inference relies on general E2 enzyme principles (small size, catalytic cysteine, covalent transfer mechanism) and elimination of alternatives by absence of their characteristic features. While the Bil system is a 2024 discovery and the sequence homology to canonical eukaryotic E2s is low, the structural/size/catalytic-cysteine pattern is a transferable family-level principle that distinguishes B from the other three options without requiring recall of this specific protein's annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A and C are clearly eliminable by absence of required structural motifs. Option D is excluded by the GO definition requiring no covalent modification, which conflicts with the catalytic cysteine implying covalent transfer. Only B remains as a consistent choice.


### Important caveats

- The Bil (bacterial ISG15-like) system was only described in 2024 (Nature, PubMed:39020165); before this, E2-like ubiquitin transferase activity was considered exclusively eukaryotic. A model trained on pre-2024 data might not readily assign this activity to a bacterial protein.
- Sequence homology of BilB to canonical eukaryotic E2/UBC-domain enzymes is low; the analogy is structural/functional rather than sequence-based, making fold recognition from sequence alone more challenging.
- The catalytic cysteine context (IPCDR at position 113) does not match canonical eukaryotic E2 catalytic-site motifs, so the inference relies on general principles (small size + catalytic Cys → transferase) rather than direct motif matching.
- The GO annotation evidence code is IDA (Inferred from Direct Assay) from the 2024 Nature paper, indicating experimental support rather than computational prediction.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A knowledgeable model can apply several transferable principles: (1) E2 ubiquitin-conjugating enzymes are characteristically small (~150-200 AA) with a catalytic cysteine; this protein is 161 AA with a probable catalytic Cys-113 in the context 'IPCDR', fitting the E2 size/catalytic-cysteine paradigm. (2) Option A (peptidyl-lysine 3-dioxygenase) requires 2-oxoglutarate-dependent dioxygenase motifs (Fe(II)-coordinating HxD/E...H triad, larger protein ~300+ AA); none are present. (3) Option C (potassium channel regulator) requires channel-binding domains and often transmembrane segments; the sequence lacks both. (4) Option D (enzyme activator, GO:0008047) is defined as increasing catalytic activity WITHOUT covalent modification; a catalytic cysteine in a small protein implies covalent transfer chemistry, which contradicts the activator definition and aligns with E2 transferase. The combination of small size + catalytic Cys + absence of dioxygenase/channel features + covalent-modification implication meaningfully favors B over the alternatives.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The inference relies on general E2 enzyme principles (small size, catalytic cysteine, covalent transfer mechanism) and elimination of alternatives by absence of their characteristic features. While the Bil system is a 2024 discovery and the sequence homology to canonical eukaryotic E2s is low, the structural/size/catalytic-cysteine pattern is a transferable family-level principle that distinguishes B from the other three options without requiring recall of this specific protein's annotation."
  },
  "case_id": "GO_molecular_function_0060",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C7",
      "C8",
      "H3",
      "H5"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0A1I1NU27 explicitly annotates this protein with GO:0019787 (ubiquitin-like protein transferase activity) with evidence code IDA:UniProtKB, backed by experimental evidence from PubMed:39020165 (Hoer, Wolf, Sorek, Nature 2024). The protein is named 'Bacterial E2-like ubiquitin protein BilB' (EC 2.3.2.-) and functions as the E2 component of the Bil antiviral defense system, conjugating ubiquitin-like moieties to phage target proteins. The GO term definition (catalysis of transfer of a ubiquitin-like from one protein to another via covalent linkage) matches the described mechanism."
  },
  "important_caveats": [
    "The Bil (bacterial ISG15-like) system was only described in 2024 (Nature, PubMed:39020165); before this, E2-like ubiquitin transferase activity was considered exclusively eukaryotic. A model trained on pre-2024 data might not readily assign this activity to a bacterial protein.",
    "Sequence homology of BilB to canonical eukaryotic E2/UBC-domain enzymes is low; the analogy is structural/functional rather than sequence-based, making fold recognition from sequence alone more challenging.",
    "The catalytic cysteine context (IPCDR at position 113) does not match canonical eukaryotic E2 catalytic-site motifs, so the inference relies on general principles (small size + catalytic Cys → transferase) rather than direct motif matching.",
    "The GO annotation evidence code is IDA (Inferred from Direct Assay) from the 2024 Nature paper, indicating experimental support rather than computational prediction."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and C are clearly eliminable by absence of required structural motifs. Option D is excluded by the GO definition requiring no covalent modification, which conflicts with the catalytic cysteine implying covalent transfer. Only B remains as a consistent choice."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_molecular_function_0060",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0A1I1NU27 explicitly annotates this protein with GO:0019787 (ubiquitin-like protein transferase activity) with evidence code IDA:UniProtKB, backed by experimental evidence from PubMed:39020165 (Hoer, Wolf, Sorek, Nature 2024). The protein is named 'Bacterial E2-like ubiquitin protein BilB' (EC 2.3.2.-) and functions as the E2 component of the Bil antiviral defense system, conjugating ubiquitin-like moieties to phage target proteins. The GO term definition (catalysis of transfer of a ubiquitin-like from one protein to another via covalent linkage) matches the described mechanism.",
    "evidence_ids": ["C4", "C5", "C7", "C8", "H3", "H5"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "A knowledgeable model can apply several transferable principles: (1) E2 ubiquitin-conjugating enzymes are characteristically small (~150-200 AA) with a catalytic cysteine; this protein is 161 AA with a probable catalytic Cys-113 in the context 'IPCDR', fitting the E2 size/catalytic-cysteine paradigm. (2) Option A (peptidyl-lysine 3-dioxygenase) requires 2-oxoglutarate-dependent dioxygenase motifs (Fe(II)-coordinating HxD/E...H triad, larger protein ~300+ AA); none are present. (3) Option C (potassium channel regulator) requires channel-binding domains and often transmembrane segments; the sequence lacks both. (4) Option D (enzyme activator, GO:0008047) is defined as increasing catalytic activity WITHOUT covalent modification; a catalytic cysteine in a small protein implies covalent transfer chemistry, which contradicts the activator definition and aligns with E2 transferase. The combination of small size + catalytic Cys + absence of dioxygenase/channel features + covalent-modification implication meaningfully favors B over the alternatives.",
    "missing_item_specific_fact": "",
    "reason": "The inference relies on general E2 enzyme principles (small size, catalytic cysteine, covalent transfer mechanism) and elimination of alternatives by absence of their characteristic features. While the Bil system is a 2024 discovery and the sequence homology to canonical eukaryotic E2s is low, the structural/size/catalytic-cysteine pattern is a transferable family-level principle that distinguishes B from the other three options without requiring recall of this specific protein's annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and C are clearly eliminable by absence of required structural motifs. Option D is excluded by the GO definition requiring no covalent modification, which conflicts with the catalytic cysteine implying covalent transfer. Only B remains as a consistent choice."
  },
  "important_caveats": [
    "The Bil (bacterial ISG15-like) system was only described in 2024 (Nature, PubMed:39020165); before this, E2-like ubiquitin transferase activity was considered exclusively eukaryotic. A model trained on pre-2024 data might not readily assign this activity to a bacterial protein.",
    "Sequence homology of BilB to canonical eukaryotic E2/UBC-domain enzymes is low; the analogy is structural/functional rather than sequence-based, making fold recognition from sequence alone more challenging.",
    "The catalytic cysteine context (IPCDR at position 113) does not match canonical eukaryotic E2 catalytic-site motifs, so the inference relies on general principles (small size + catalytic Cys → transferase) rather than direct motif matching.",
    "The GO annotation evidence code is IDA (Inferred from Direct Assay) from the 2024 Nature paper, indicating experimental support rather than computational prediction."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A1I1NU27",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "3646da7e5f755e00a2cd4a2c090e3de055c0fb0383323a7b1c9eea3986ed9213",
  "benchmark_sequence_length": 161,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 12,
    "firstPublicDate": "2025-04-09",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2017-11-22",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "current_source_sequence_sha256": "3646da7e5f755e00a2cd4a2c090e3de055c0fb0383323a7b1c9eea3986ed9213",
  "current_source_sequence_length": 161,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 11,
  "selected_historical_version": {
    "accession": "A0A1I1NU27",
    "database": "Swiss-Prot",
    "entryVersion": 11,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_02/2026_02",
    "lastReleaseDate": "10-Jun-2026",
    "name": "BILB_COLS4",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "02140c806e50b7c8fba6442df748ac8050a6b50ee7a254e8a2d0deb6a7a2c0c9",
  "selected_historical_source_sequence_sha256": "3646da7e5f755e00a2cd4a2c090e3de055c0fb0383323a7b1c9eea3986ed9213",
  "selected_historical_source_sequence_length": 161,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 11,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A1I1NU27\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":12,\"firstPublicDate\":\"2025-04-09\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2017-11-22\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Bacteria\",\"Pseudomonadati\",\"Pseudomonadota\",\"Betaproteobacteria\",\"Burkholderiales\",\"Oxalobacteraceae\",\"Collimonas\"],\"scientificName\":\"Collimonas sp. (strain OK412)\",\"taxonId\":1801619}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"value\":\"E2 ubiquitin-conjugating enzyme BilB\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39020165\",\"source\":\"PubMed\"}],\"value\":\"2.3.2.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39020165\",\"source\":\"PubMed\"}],\"value\":\"Bacterial E2-like ubiquitin protein BilB\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/comments/0",
  "excerpt": "{\"commentType\":\"FUNCTION\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39020165\",\"source\":\"PubMed\"},{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39020165\",\"source\":\"PubMed\"}],\"value\":\"Component of the Bil (bacterial ISG15-like) antiviral defense system, composed of BilA, BilB, BilC and BilD. The Bil system specifically conjugates a ubiquitin-like moiety (bilA) to the bacteriophage central tail fiber (CTF, or tip attachment protein J) via reactions involving E1 (bilD) and E2 (bilB). Modifies CTF of phage SECphi27 and SECphi4, which probably interferes with assembly of the phage tail. Also modifies T5 baseplate hub protein pb3 (gene D16), but not gp27 of phage T6 (Bil defends against T6). BilB probably accepts ubiquitin from the BilA-BilD (E1) complex and catalyzes its covalent attachment to target protein (CTF) (Probable) (PubMed:39020165). Bil-encoding bacteria produce mostly defective phage SECphi27, many of which have phage assembly defects, including no tails. SECphi27 phage progeny produced in E.coli with the Bil system inject less DNA into naive host cells, maybe because the phage are less able to adsorb and inject their DNA into host cells\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/comments/1",
  "excerpt": "{\"commentType\":\"FUNCTION\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39020165\",\"source\":\"PubMed\"}],\"value\":\"Expression of the Bil system in E.coli (strain MG1655) confers about 100-fold resistance to phage SECphi27, SECphi18, SECphi6, SECphi4 and T5, but not to SECphi17. When cells expressing the Bil system are infected by phage SECphi27 at low multiplicity of infection (0.03 MOI) the culture survives, at 3.0 MOI the culture collapses at the same time as cells without the Bil system\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C7",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/uniProtKBCrossReferences/5",
  "excerpt": "{\"database\":\"GO\",\"evidences\":[{\"evidenceCode\":\"ECO:0000314\",\"id\":\"39020165\",\"source\":\"PubMed\"}],\"id\":\"GO:0019787\",\"properties\":[{\"key\":\"GoTerm\",\"value\":\"F:ubiquitin-like protein transferase activity\"},{\"key\":\"GoEvidenceType\",\"value\":\"IDA:UniProtKB\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C8

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)

```json
{
  "evidence_id": "C8",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json",
  "source_sha256": "dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399",
  "retrieved_utc": "2026-11-02T04:24:36.666780+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Hoer J.\",\"Wolf S.G.\",\"Sorek R.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39020165\"},{\"database\":\"DOI\",\"id\":\"10.1038/s41586-024-07616-5\"}],\"citationType\":\"journal article\",\"firstPage\":\"850\",\"id\":\"39020165\",\"journal\":\"Nature\",\"lastPage\":\"856\",\"publicationDate\":\"2024\",\"title\":\"Bacteria conjugate ubiquitin-like proteins to interfere with phage assembly.\",\"volume\":\"631\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"PROBABLE ACTIVE SITE\",\"MUTAGENESIS OF CYS-113\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11",
  "source_sha256": "02140c806e50b7c8fba6442df748ac8050a6b50ee7a254e8a2d0deb6a7a2c0c9",
  "retrieved_utc": "2026-11-02T04:24:42.543529+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   BILB_COLS4              Reviewed;         161 AA.\nAC   A0A1I1NU27;\nDT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.\nDT   22-NOV-2017, sequence version 1.\nDT   28-JAN-2026, entry version 11.\nDE   RecName: Full=Bacterial E2-like ubiquitin protein BilB {ECO:0000303|PubMed:39020165};\nDE            EC=2.3.2.- {ECO:0000305|PubMed:39020165};\nDE   AltName: Full=E2 ubiquitin-conjugating enzyme BilB;\nGN   Name=bilB {ECO:0000303|PubMed:39020165};\nGN   ORFNames=SAMN04515619_11957 {ECO:0000312|EMBL:SFD01174.1};\nOS   Collimonas sp. (strain OK412).\nOC   Bacteria; Pseudomonadati; Pseudomonadota; Betaproteobacteria;\nOC   Burkholderiales; Oxalobacteraceae; Collimonas.\nOX   NCBI_TaxID=1801619;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 11,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11",
  "source_sha256": "02140c806e50b7c8fba6442df748ac8050a6b50ee7a254e8a2d0deb6a7a2c0c9",
  "retrieved_utc": "2026-11-02T04:24:42.543529+00:00",
  "source_locator": "lines 20-26",
  "excerpt": "RN   [2]\nRP   FUNCTION, PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-113.\nRX   PubMed=39020165; DOI=10.1038/s41586-024-07616-5;\nRA   Hoer J., Wolf S.G., Sorek R.;\nRT   \"Bacteria conjugate ubiquitin-like proteins to interfere with phage\nRT   assembly.\";\nRL   Nature 631:850-856(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 11,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11",
  "source_sha256": "02140c806e50b7c8fba6442df748ac8050a6b50ee7a254e8a2d0deb6a7a2c0c9",
  "retrieved_utc": "2026-11-02T04:24:42.543529+00:00",
  "source_locator": "lines 27-42",
  "excerpt": "CC   -!- FUNCTION: Component of the Bil (bacterial ISG15-like) antiviral defense\nCC       system, composed of BilA, BilB, BilC and BilD. The Bil system\nCC       specifically conjugates a ubiquitin-like moiety (bilA) to the\nCC       bacteriophage central tail fiber (CTF, or tip attachment protein J) via\nCC       reactions involving E1 (bilD) and E2 (bilB). Modifies CTF of phage\nCC       SECphi27 and SECphi4, which probably interferes with assembly of the\nCC       phage tail. Also modifies T5 baseplate hub protein pb3 (gene D16), but\nCC       not gp27 of phage T6 (Bil defends against T6). BilB probably accepts\nCC       ubiquitin from the BilA-BilD (E1) complex and catalyzes its covalent\nCC       attachment to target protein (CTF) (Probable) (PubMed:39020165). Bil-\nCC       encoding bacteria produce mostly defective phage SECphi27, many of\nCC       which have phage assembly defects, including no tails. SECphi27 phage\nCC       progeny produced in E.coli with the Bil system inject less DNA into\nCC       naive host cells, maybe because the phage are less able to adsorb and\nCC       inject their DNA into host cells. {ECO:0000269|PubMed:39020165,\nCC       ECO:0000305|PubMed:39020165}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 11,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11)

```json
{
  "evidence_id": "H4",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11",
  "source_sha256": "02140c806e50b7c8fba6442df748ac8050a6b50ee7a254e8a2d0deb6a7a2c0c9",
  "retrieved_utc": "2026-11-02T04:24:42.543529+00:00",
  "source_locator": "lines 43-53",
  "excerpt": "CC   -!- FUNCTION: Expression of the Bil system in E.coli (strain MG1655)\nCC       confers about 100-fold resistance to phage SECphi27, SECphi18, SECphi6,\nCC       SECphi4 and T5, but not to SECphi17. When cells expressing the Bil\nCC       system are infected by phage SECphi27 at low multiplicity of infection\nCC       (0.03 MOI) the culture survives, at 3.0 MOI the culture collapses at\nCC       the same time as cells without the Bil system.\nCC       {ECO:0000269|PubMed:39020165}.\nCC   ---------------------------------------------------------------------------\nCC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\nCC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\nCC   ---------------------------------------------------------------------------\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 11,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11)

```json
{
  "evidence_id": "H5",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11",
  "source_sha256": "02140c806e50b7c8fba6442df748ac8050a6b50ee7a254e8a2d0deb6a7a2c0c9",
  "retrieved_utc": "2026-11-02T04:24:42.543529+00:00",
  "source_locator": "lines 59-59",
  "excerpt": "DR   GO; GO:0019787; F:ubiquitin-like protein transferase activity; IDA:UniProtKB.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 11,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence GO1

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO1",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 78691-78702",
  "excerpt": "[Term]\nid: GO:0008047\nname: enzyme activator activity\nnamespace: molecular_function\nalt_id: GO:0010577\ndef: \"A molecular function regulator that increases a catalytic activity.\" [GOC:pdt]\ncomment: This term should only be used in cases when the regulator directly interacts with the enzyme, but does not result in a covalent modification.\nsynonym: \"metalloenzyme activator activity\" NARROW []\nxref: Reactome:R-HSA-9948070 \"POMGNT1 catalyzes FKRP:FKTN:RXYLT1 formation\"\nis_a: GO:0030234 ! enzyme regulator activity\nis_a: GO:0140677 ! molecular function activator activity\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0008047"
}
```

### Evidence GO2

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO2",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 117999-118006",
  "excerpt": "[Term]\nid: GO:0015459\nname: potassium channel regulator activity\nnamespace: molecular_function\ndef: \"Binds to and modulates the activity of a potassium channel.\" [GOC:dos, GOC:mah]\nsynonym: \"potassium channel gating activity\" EXACT []\nis_a: GO:0099106 ! ion channel regulator activity\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0015459"
}
```

### Evidence GO3

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO3",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 153098-153118",
  "excerpt": "[Term]\nid: GO:0019787\nname: ubiquitin-like protein transferase activity\nnamespace: molecular_function\nalt_id: GO:0008639\nalt_id: GO:0008640\ndef: \"Catalysis of the transfer of a ubiquitin-like from one protein to another via the reaction X-ULP + Y = Y-ULP + X, where both X-ULP and Y-ULP are covalent linkages. ULP represents a ubiquitin-like protein.\" [GOC:mah, GOC:rn, PMID:10806345, PMID:10884686]\nsubset: goslim_drosophila\nsubset: goslim_pir\nsynonym: \"E2\" BROAD []\nsynonym: \"E3\" RELATED [GOC:dph]\nsynonym: \"small conjugating protein ligase activity\" NARROW [GOC:dph]\nsynonym: \"small conjugating protein transferase activity\" EXACT [GOC:dph]\nsynonym: \"small protein conjugating enzyme activity\" NARROW []\nsynonym: \"ubiquitin-like conjugating enzyme activity\" NARROW []\nsynonym: \"ubiquitin-like-protein ligase activity\" NARROW []\nxref: Reactome:R-HSA-5678490 \"ATG16L1 complex transfers LC3 from ATG3 to PE\"\nxref: Reactome:R-HSA-688137 \"RIP2 is K63 polyubiquitinated\"\nis_a: GO:0016755 ! aminoacyltransferase activity\nis_a: GO:0140096 ! catalytic activity, acting on a protein\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0019787"
}
```

### Evidence GO4

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO4",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 428071-428084",
  "excerpt": "[Term]\nid: GO:0106155\nname: peptidyl-lysine 3-dioxygenase activity\nnamespace: molecular_function\ndef: \"Catalysis of the reaction: protein L-lysine + 2-oxoglutarate + O2 = protein 3-hydroxy-L-lysine + succinate + CO2.\" [GOC:al, PMID:29915238, RHEA:57152]\nxref: EC:1.14.11.63\nxref: Reactome:R-HSA-9629578 \"JMJD7 dimer hydroxlates a lysine residue of DRG2\"\nxref: Reactome:R-HSA-9629591 \"JMJD7 dimer hydroxlates a lysine residue of DRG1\"\nxref: RHEA:57152\nis_a: GO:0016706 ! 2-oxoglutarate-dependent dioxygenase activity\nis_a: GO:0140096 ! catalytic activity, acting on a protein\nproperty_value: skos:exactMatch EC:1.14.11.63\nproperty_value: skos:exactMatch RHEA:57152\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0106155"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_molecular_function.json), zero-based source row 60. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
